期刊
ANNALS OF TRANSLATIONAL MEDICINE
卷 5, 期 14, 页码 -出版社
AME PUBL CO
DOI: 10.21037/atm.2017.06.58
关键词
Acute respiratory distress syndrome (ARDS); extracorporeal membrane oxygenation (ECMO); respiratory failure; extracorporeal life support; extracorporeal carbon dioxide removal (ECCO2R)
Extracorporeal membrane oxygenation (ECMO) was first introduced for patients with acute respiratory distress syndrome (ARDS) in the 1970s. However, enthusiasm was tempered due to the high mortality seen at that time. The use of ECMO has grown considerably in recent years due to technological advances and the evidence suggesting potential benefit. While the efficacy of ECMO has yet to be rigorously demonstrated with high-quality evidence, it has the potential not only to have a substantial impact on outcomes, including mortality, but also to change the paradigm of ARDS management.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据